Amniotic fluid volume changes in response to frusemide induced maternal fluid shifts
K. Manikandan1★, S. Raghavan1★ Corresponding author
- 1Department of Obstetrics and Gynaecology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
CORRESPONDENCE
K. Manikandan
Department of Obstetrics and Gynaecology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Received: 17-03-2013; Revised: 29-05-2013; Accepted: 16-06-2013.
Volume 5, Issue 2 · pp. 153–154 · PUBLISHED 2014 · DOI: 10.4103/0976-500X.130075
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Frusemide use in pregnancy is generally restricted to patients with cardiac decompensation. In the past, maternal administration of oral frusemide had been tried to identify non-functioning fetal kidneys by utilizing the diuretic effect of frusemide on the fetal kidneys. We report a case of primigravida with severe mitral stenosis presenting in pulmonary edema that received high dose of frusemide. This was associated with the development of transient oligohydramnios. We discuss the clinical significance of this observation and the possible explanations.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Manikandan, K., & Raghavan, S. (2014). Amniotic fluid volume changes in response to frusemide induced maternal fluid shifts. Journal of Pharmacology and Pharmacotherapeutics, 5(2), 153–154. https://doi.org/10.4103/0976-500X.130075
